Departing BCU Board Members Leave Legacy of Progress, InnovationMarch 27, 2017
BCU announced two members of its board of directors have concluded their service in 2017. Stepping down are board members Michael J. Baughman and Ron K. Labrum.
Michael J. Baughman is currently Vice President, Finance Operations, CSO and Quality for Baxter International. He joined Baxter in 2003 as Vice President of Corporate Audit and was appointed Corporate Vice President and Controller in 2006. Before joining Baxter, he spent 16 years at PricewaterhouseCoopers LLP, in roles of increasing responsibility which included Audit Partner and Partner in the firm’s mergers and acquisition practice. Mike is a CPA and holds a Bachelor of Science in Business Administration from the University of Michigan’s Stephen M. Ross School of Business.
Ron K. Labrum is an experienced operator and leader in healthcare distribution and medical device sectors. He began his career with American Hospital Supply and spent over 25 years with Baxter International, Allegiance Healthcare, and CardinalHealth. Mr. Labrum’s career has been distinguished by leadership roles in sales, operations, and manufacturing in addition to execution and integration of several mergers and acquisitions. Most recently, Ron was CEO of Fenwal, Inc., a private equity backed spinout of Baxter’s device business focused on blood technologies. He led Fenwal for six years prior to a successful sale of the company to Fresenius SE & Co. Mr. Labrum also serves on the boards of OrthoClinical Diagnostics, Wright Medical, Aptalis, and Suture Express. He holds a Bachelor of Science in Business Administration from Utah State University.
“Mike and Ron helped guide our company through many changes in our economy and the marketplace,” BCU President/CEO Mike Valentine said. “These individuals have dedicated their time and service to BCU for many years, and I sincerely thank them both for their many contributions, and their strong, steady leadership.”